Navigation Links
New technique extends cancer-fighting cells' potency in melanoma patients
Date:4/27/2011

BOSTON--Like brainy bookworms unprepared for the rough and tumble of post-graduation life, white blood cells trained by scientists to attack tumors tend to fade away quickly when injected into cancer patients. Dana-Farber Cancer Institute scientists, however, have developed a technique that can cause such cells to survive in patients' bloodstreams for well over a year, in some cases, without the need of other, highly toxic treatments, a new study shows.

In a paper published in the Apr. 27 issue of Science Translational Medicine, the researchers report the results of a small, Phase I study in which the technique -- a form of "adoptive immunotherapy" -- was tested in nine patients with advanced melanoma. Ten weeks after starting the therapy, seven of the nine patients had more of the specially trained, tumor-hunting cells than they had started with. Three of the patients had stable disease -- neither advancing nor retreating -- and one had shrinkage of a tumor that had spread to the lung. Another patient experienced a complete remission, with no tumors visible on CT or PET scans. Today, 25 months after receiving the one-time therapy, he has no evidence of cancer.

The results represent the longest that the injected cells -- known as anti-tumor T cells -- have ever endured in cancer patients without the use of supplemental treatments -- treatments that, while effective, often have harsh side effects. "The study demonstrates it is possible to maintain high levels of anti-tumor T cells in patients over a long period of time while avoiding the complications of conventional approaches," says the study's lead author, Marcus Butler, MD, of Dana-Farber's Early Drug Development Center. "Our technique opens the way to therapies that produce less-toxic, long-lasting immune system attacks on cancer cells."

The technique's promise was further illustrated when researchers combined it with another treatment. Five patients whose disease had p
'/>"/>

Contact: Anne Doerr
anne_doerr@dfci.harvard.edu
617-632-5665
Dana-Farber Cancer Institute
Source:Eurekalert  

Page: 1 2 3 4

Related medicine news :

1. The New Liposuction Technique Means No Surgery or Suction
2. The Future of Cosmetic Dermatology: Leading Dermatologist Dr. David Goldberg Discusses the Latest Facial Rejuvenation Techniques
3. New DNA technique leads to a breakthrough in child cancer research
4. New Study Tunes Into Latest Lipo Technique
5. Freezing Technique May Stop Breast Cancer
6. Non-drug techniques reduce pain in hospitalized patients
7. New cancer drug screening technique more closely mirrors reality
8. New technique reduces tobacco smoke damage to lungs in mice
9. Recent Studies Show MAstertuck℠ Technique Removes Large Amounts of Body Fat without Tummy Tuck Surgery
10. A new endoscopic technique for gastrointestinal perforations: the over-the-scope-clip
11. TCT for Surgeons course will highlight hybrid surgical and interventional techniques
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New technique extends cancer-fighting cells' potency in melanoma patients
(Date:8/31/2015)... Scotch Plains, NJ (PRWEB) , ... August 31, 2015 , ... ... years as an “NJ Top Doc.” , At OSSMC, Dr. Kovatis treats all surgical ... general orthopedics and traumatic injuries to the entire musculoskeletal system, excluding the spine. , ...
(Date:8/31/2015)... , ... August 31, 2015 , ... ... digital marketing communications company announced today that it has officially launched a new ... the new website and brand refresh are more closely aligned with the company’s ...
(Date:8/31/2015)... ... August 31, 2015 , ... Finnleo is pleased to ... Outdoor Sauna. After months of extensive engineering and design of our newest sauna model, ... the elements and is offered at a very attractive price-point. , Before outdoor ...
(Date:8/31/2015)... ... August 31, 2015 , ... Wyoming Medical Center, an acute ... its Clinical Documentation Improvement (CDI) and medical coding needs. Based on a proprietary ... ezCAC is an enterprise-level coding solution that combines CDI, Coding, Quality and Compliance ...
(Date:8/31/2015)... ... August 31, 2015 , ... Castle Dermatology Institute now welcomes San Fernando ... a graduate of the University of California, Los Angeles. He graduated summa cum laude ... of California, Irvine Medical School. As a nationally recognized Regents Scholar, Dr. Ghasri was ...
Breaking Medicine News(10 mins):Health News:NJ Top Docs Presents, Dr. Paul Kovatis of Orthopedic Spine & Sports Medicine Center on his Five Year Anniversary as an "NJ Top Doc" 2Health News:Diablo Publications Launches New Company Website 2Health News:Diablo Publications Launches New Company Website 3Health News:Say “Hello” to the Brand New Finnleo Terrace Outdoor Saunas 2Health News:Wyoming Medical Center Selects ezDI’s CAC/CDI Solution Based on Integrated Healthcare Data Management, Workflow Design and ROI 2Health News:Wyoming Medical Center Selects ezDI’s CAC/CDI Solution Based on Integrated Healthcare Data Management, Workflow Design and ROI 3Health News:Wyoming Medical Center Selects ezDI’s CAC/CDI Solution Based on Integrated Healthcare Data Management, Workflow Design and ROI 4Health News:Castle Dermatology Institute Now Welcomes Dr. Pedram Ghasri to the Practice 2
... /PRNewswire/ - Neuromed Pharmaceuticals Ltd. announced today that it ... terminate the research collaboration and license agreement for novel ... pain and other disorders, which the companies entered into ... years we have had an excellent and extremely productive ...
... and Communities Critical to Wellness Efforts , , LOS ... the National Childhood Obesity Conference in Los Angeles highlights the ... health crisis caused by childhood obesity. More than 15 ... contributing to skyrocketing type 2 diabetes rates and more than ...
... The Merz Scales(TM) are the most comprehensive rating system to ... than 34 years , , LAS VEGAS, June 11 ... to measure the skin,s aging process, were presented at THE ... of multidisciplinary experts to "establish a universal language of aging," ...
... at August Luncheon , , DENVER, June 11 ... of kidney care services for those diagnosed with chronic kidney ... the Los Angeles Business Journal ,s 2009 "Best Places ... 67 companies chosen for their impact on the region,s economy, ...
... ... Project , ... (PRWEB) June 11, 2009 -- The Critical Access Hospital (CAH) Quality Network of the ... risk, quality and patient safety software and consulting services have joined forces to carry ...
... information, study shows , THURSDAY, June 11 (HealthDay News) -- ... seems to store only the most useful information, researchers have ... students aged 18 to 22, the study findings showed that ... sleep can preserve the most important memories for as long ...
Cached Medicine News:Health News:Neuromed Announces that Merck & Co., Inc. Terminates Research Collaboration and License Agreement for Compounds Targeting N-Type Calcium Channels 2Health News:Kaiser Permanente Calls for Health Policy Support and Community Advocacy to Curb Childhood Obesity 2Health News:Kaiser Permanente Calls for Health Policy Support and Community Advocacy to Curb Childhood Obesity 3Health News:First-Ever Standardized Scales to Measure the Skin's Aging Process Are Presented at THE Aesthetic Show 2Health News:DaVita Named to List of 'Best Places to Work in Los Angeles' by the Los Angeles Business Journal 2Health News:North Dakota Critical Access Hospital Quality Network Moves Forward with Statewide Information Management Project to Enhance Patient Safety in the State 2Health News:North Dakota Critical Access Hospital Quality Network Moves Forward with Statewide Information Management Project to Enhance Patient Safety in the State 3
(Date:8/31/2015)... , Aug. 31, 2015 Pepperl+Fuchs, a ... acquired MACTek Corporation, a leading provider of HART ... strategy to further extend its integrated solutions offerings ...   "We are pleased to add ... portfolio," said Jim Bolin , Pepperl+Fuchs, executive ...
(Date:8/31/2015)... , Aug. 31, 2015  Daktari Diagnostics today announced ... the United States and Canada ... test. The deal, worth up to $8.5 million over the ... the clinical validation and regulatory approval of Daktari,s HCV test. ... a point-of-care instrument that can detect low levels of virus ...
(Date:8/31/2015)... , Aug. 31, 2015  On August 5, ... Oregon denied motions to dismiss ... GALE ) and certain of its directors. The ... a "pump and dump" scheme to artificially inflate Galena,s ... while the stock price was inflated, sold massive amounts ...
Breaking Medicine Technology:Daktari Enters Collaboration Agreement with Merck to Develop Test for Hepatitis C Virus 2Daktari Enters Collaboration Agreement with Merck to Develop Test for Hepatitis C Virus 3Galena Biopharma, Inc. Stock Alert: Schubert Firm Investigates Potential Breaches of Fiduciary Duty 2
... , , , SAN DIEGO, ... dedicated to developing life-saving medicines specifically designed to enhance ... through targeted oxygen delivery, today announced the initiation of ... efficacy of MP4OX treatment plus standard of care in ...
... Dec. 9 The U.S. Food and Drug Administration ... workshop series--an opportunity for biotechnology companies, pharmaceutical firms, academics ... applications for orphan status designation, under the guidance of ... The first workshop is planned for Feb. 25-26, 2010, ...
Cached Medicine Technology:Sangart, Inc. Initiates Phase IIa Study of Oxygen Therapeutic Agent MP4OX in Severe Trauma Patients With Hemorrhagic Shock 2Sangart, Inc. Initiates Phase IIa Study of Oxygen Therapeutic Agent MP4OX in Severe Trauma Patients With Hemorrhagic Shock 3FDA Launches Orphan Drug Workshop at KGI 2
Introducer Sheath Designed for Vascular Access...
Used to introduce balloon, electrode, closed or non-tapered end and,other catheters....
... The Driver Stent design, ... surpasses the limitations of stainless ... makes possible thinner struts, for ... support. The Driver Coronary Stent ...
The TAXUS Express Paclitaxel-Eluting Coronary Stent System is indicated for improving luminal diameter for the treatment of de novo lesions = 28 mm in length in native coronary arteries = 2.5 to = 3....
Medicine Products: